InMed Pharmaceuticals, Inc. (INM)
1.33
-0.02
(-1.48%)
USD |
NASDAQ |
Oct 02, 16:00
1.333
0.00 (0.00%)
After-Hours: 20:00
InMed Pharmaceuticals Price : 1.33 for Oct. 2, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 02, 2026 | 1.370 | 1.385 | 1.33 | 1.33 | 28338.00 |
| Oct 01, 2026 | 1.34 | 1.370 | 1.32 | 1.35 | 99970.00 |
| Sep 30, 2026 | 1.35 | 1.410 | 1.34 | 1.36 | 60668.00 |
| Sep 29, 2026 | 1.35 | 1.42 | 1.34 | 1.375 | 60531.00 |
| Sep 28, 2026 | 1.364 | 1.37 | 1.36 | 1.36 | 17395.00 |
| Sep 25, 2026 | 1.38 | 1.40 | 1.35 | 1.38 | 101106.0 |
| Sep 24, 2026 | 1.39 | 1.42 | 1.37 | 1.40 | 38964.00 |
| Sep 23, 2026 | 1.39 | 1.41 | 1.375 | 1.38 | 53681.00 |
| Sep 22, 2026 | 1.39 | 1.442 | 1.37 | 1.39 | 38336.00 |
| Sep 21, 2026 | 1.375 | 1.46 | 1.37 | 1.38 | 120104.0 |
| Sep 18, 2026 | 1.39 | 1.40 | 1.36 | 1.36 | 11242.00 |
| Sep 17, 2026 | 1.49 | 1.505 | 1.32 | 1.39 | 317248.0 |
| Sep 16, 2026 | 1.26 | 1.31 | 1.26 | 1.28 | 54946.00 |
| Sep 15, 2026 | 1.27 | 1.31 | 1.25 | 1.28 | 79056.00 |
| Sep 14, 2026 | 1.29 | 1.32 | 1.27 | 1.30 | 58462.00 |
| Sep 11, 2026 | 1.33 | 1.35 | 1.29 | 1.29 | 28135.00 |
| Sep 10, 2026 | 1.31 | 1.34 | 1.29 | 1.31 | 20500.00 |
| Sep 09, 2026 | 1.310 | 1.33 | 1.28 | 1.31 | 52816.00 |
| Sep 08, 2026 | 1.36 | 1.39 | 1.31 | 1.33 | 63669.00 |
| Sep 04, 2026 | 1.339 | 1.397 | 1.33 | 1.38 | 9542.00 |
| Sep 03, 2026 | 1.341 | 1.41 | 1.32 | 1.33 | 45539.00 |
| Sep 02, 2026 | 1.36 | 1.40 | 1.33 | 1.35 | 19980.00 |
| Sep 01, 2026 | 1.35 | 1.35 | 1.30 | 1.32 | 104483.0 |
| Aug 31, 2026 | 1.36 | 1.42 | 1.35 | 1.35 | 90046.00 |
| Aug 28, 2026 | 1.425 | 1.43 | 1.38 | 1.38 | 111947.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| NervGen Pharma Corp. | 1.78 |
| Milestone Pharmaceuticals, Inc. | 0.8097 |
| Clearmind Medicine, Inc. | 0.715 |
| Lexaria Bioscience Corp. | 2.88 |
| Target Group, Inc. (Canada) | 0.0007 |
Price Related Metrics
| PS Ratio | 2.798 |
| Price to Book Value | 6.606 |
| Earnings Yield | -234.3% |
| Market Cap | 7.101M |